Abbott (ABT) Dips More Than Broader Markets: What You Should Know

- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Abbott (ABT) closed the most recent trading day at $81.90, moving -1% from the previous trading session. This move lagged the S&P 500’s daily loss of 0.16%. Elsewhere, the Dow lost 0.12%, while the tech-heavy Nasdaq lost 0.33%.

Heading into today, shares of the maker of infant formula, medical devices and drugs had gained 7.41% over the past month, outpacing the Medical sector’s loss of 8.16% and the S&P 500’s loss of 10.5% in that time.

ABT will be looking to display strength as it nears its next earnings release, which is expected to be April 16, 2020. The company is expected to report EPS of $0.62, down 1.59% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $7.64 billion, up 1.4% from the year-ago period.

For the full year, our Zacks Consensus Estimates are projecting earnings of $3.26 per share and revenue of $32.17 billion, which would represent changes of +0.62% and +0.84%, respectively, from the prior year.

It is also important to note the recent changes to analyst estimates for ABT. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company’s business outlook.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 9.39% lower. ABT is holding a Zacks Rank of #4 (Sell) right now.

Looking at its valuation, ABT is holding a Forward P/E ratio of 25.38. Its industry sports an average Forward P/E of 24.63, so we one might conclude that ABT is trading at a premium comparatively.

Home of Science
Follow me

- Advertisement -




Ncuti Gatwa: BBC names actor as next Doctor Who staron May 8, 2022 at 11:37 am

Ncuti Gatwa will replace Jodie Whittaker as the Doctor in the BBC science fiction programme.Ncuti Gatwa will take over from Jodie Whittaker as the...

How facial recognition is identifying the dead in Ukraineon April 13, 2022 at 1:08 am

A controversial facial recognition platform has been used more than 1,000 times by Ukrainian officials.

Crimea bridge: How Russia is rebuilding its vital linkon December 7, 2022 at 12:53 pm

The Kerch bridge is a key route connecting Russia and Crimea and was damaged by an explosion in October.The Kerch bridge is a key...

Graphene can be useful to prevent mosquitoes from biting

According to a group of researchers at Brown University, graphene, a very thin nanomaterial that can be as thick as a single atom, can...

Budget 2021: Key points at-a-glanceon March 3, 2021 at 1:10 pm

Rishi Sunak is delivering his annual Budget in the House of Commons. Here's what you need to know.image copyrightReutersChancellor Rishi Sunak is unveiling the...
Home of Science
Follow me